Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
55
Number of overlapping holdings
14.2%
% of VHT's 415 holdings also in WDNA
65.5%
% of WDNA's 90 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.4% | 2.7% | 2.7% |
|
GILEAD SCIENCES INC | 2.2% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.2% | 1.8% | 1.8% |
|
AMGEN INC | 2.6% | 1.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to WDNA
|
ELI LILLY & CO | 8.7% |
|
UNITEDHEALTH GROUP INC | 6.3% |
|
ABBVIE INC | 5.4% |
|
ABBOTT LABORATORIES | 4.0% |
|
JOHNSON & JOHNSON | 3.4% |
|
INTUITIVE SURGICAL INC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 2.7% |
|
MERCK & CO. INC. | 2.3% |
|
STRYKER CORP | 2.2% |
 |
MEDTRONIC PLC | 1.9% |
VHT Underweight Relative to WDNA
|
NATERA INC | -3.4% |
|
TWIST BIOSCIENCE CORP. | -3.2% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.5% |
|
BLUEPRINT MEDICINES CORP. | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.3% |
|
VERACYTE INC | -2.0% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
 |
NOVARTIS AG | -1.7% |
|
UNITED THERAPEUTICS CORP | -1.5% |